For example, Diabetes, diabetic / Type 2 / with / chronic kidney disease maps directly to E11.22 based on the index structure
"Cyanocobalamin Drug Usage Statistics, United States, 2014 - 2023"
The approved doses in China are 4 mg and 6 mg for weight management, with a 9 mg dose under review for moderate-to-severe obesity
Advanced proteomics research shows that EGCG can modulate protein interactions involved in inflammatory processes, inhibiting enzyme activities like cyclooxygenase and lipoxygenase, and providing multilayered protection against chronic inflammatory conditions
Perfield JW 2nd, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS (2013) Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice
S., Andexer, J